Biolevate's raises €6M to helps medical writers keep up with the pace of new drugs | TechCrunch
–
Biolevate raises €6M to help medical writers keep up with the pace of new drugs using NLP and computer vision to assist in the writing process.
– Biolevate's Drug Development Platform
Biolevate was founded by two long-time friends, Joel Belafa and Nathan Chen, who have expertise in AI and pharmaceutical processes respectively.
- Founders' Expertise
The biotech industry faces a significant administrative burden in creating documentation to satisfy regulators, which Biolevate aims to streamline.
- Addressing Documentation Burden
Biolevate's platform uses NLP and Computer Vision to guide medical writers, reducing the time and effort needed to understand or correct the system.
- Platform Capabilities